Global PEG Hydrogel-based Medical Device Market Growth 2024-2030
Polyethylene glycol materials have the advantages of solubility, good biocompatibility, non-toxicity, and low immunogenicity. They are also widely used in medical treatments such as wound adhesion, hemostasis, leakage prevention, and adhesion prevention in various human surgical operations. in device materials. At the same time, polyethylene glycol materials can also be used as raw materials for medical devices implanted in the human body, replacing widely used plant-source, animal-source, and human-source materials, so they have a wide range of medical uses.
After the hydrogel with polyethylene glycol derivatives as its main component is sprayed onto the wound site, the gel quickly solidifies to prevent wound bleeding and infection, and then degrades on its own after the wound heals. At the same time, this hydrogel is sprayed onto the surface of organs, which can effectively prevent adhesion of internal organs during surgery and worsen the condition. Since polyethylene glycol derivatives have good biocompatibility, this process will not cause abnormal reactions in the human body; polyethylene glycol derivatives will not be absorbed by the human body, and all polyethylene glycol derivatives will eventually be metabolized Excreted from the body.
The global PEG Hydrogel-based Medical Device market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “PEG Hydrogel-based Medical Device Industry Forecast” looks at past sales and reviews total world PEG Hydrogel-based Medical Device sales in 2023, providing a comprehensive analysis by region and market sector of projected PEG Hydrogel-based Medical Device sales for 2024 through 2030. With PEG Hydrogel-based Medical Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PEG Hydrogel-based Medical Device industry.
This Insight Report provides a comprehensive analysis of the global PEG Hydrogel-based Medical Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PEG Hydrogel-based Medical Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PEG Hydrogel-based Medical Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PEG Hydrogel-based Medical Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PEG Hydrogel-based Medical Device.
United States market for PEG Hydrogel-based Medical Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for PEG Hydrogel-based Medical Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for PEG Hydrogel-based Medical Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key PEG Hydrogel-based Medical Device players cover Baxter, Becton Dickinson, Boston Scientific, Cardinal Health, Medtronic, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of PEG Hydrogel-based Medical Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
4-Arm PEGs
8-Arm PEGs
Multi-Arm PEGs
Segmentation by Application:
Surgical Closure and Hemostasis
Radiation Therapy Tissue Barrier
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Becton Dickinson
Boston Scientific
Cardinal Health
Medtronic
Stryker
Integra LifeSciences
Pramand
Success Bio-Tech
Medprin Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global PEG Hydrogel-based Medical Device market?
What factors are driving PEG Hydrogel-based Medical Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PEG Hydrogel-based Medical Device market opportunities vary by end market size?
How does PEG Hydrogel-based Medical Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.